MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
11.98
-0.20 (-1.64%)
At close: Aug 11, 2026, 4:00 PM EDT
11.83
-0.15 (-1.25%)
After-hours: Aug 11, 2026, 6:34 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $543.24 million as of August 11, 2026.
Market Cap
543.24M
Enterprise Value
238.72M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.98
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has decreased from $704.29M to $543.24M, a decrease of -22.87%. That is a compound annual growth rate of -28.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 543.24M | -29.13% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 585.89M |
| 4D Molecular Therapeutics | 582.36M |
| Prime Medicine | 562.18M |
| Shattuck Labs | 552.87M |
| Autolus Therapeutics | 549.59M |
| Contineum Therapeutics | 548.89M |
| Artiva Biotherapeutics | 546.59M |
| Zura Bio | 539.59M |